Seoul National University

Samsung Electronics appoints Samsung Bioepis CEO Ko Han-sung to lead its Future Business Planning Division, marking a strategic shift with his biotech expertise. Ko, with a Ph.D. in genetic engineering, has steered Samsung Bioepis for 13 years and will continue his role as KoreaBIO chairman. Samsung Bioepis also names Kim Kyung-ah, its first non-founder female CEO, as its new head, symbolizing innovation and diversity.

Seoul National University scientists developed an AI-based diagnostic test for sepsis, reducing AST time by 30-40 hours, potentially preventing antimicrobial resistance and saving lives.

Seer, Inc. presents advancements at HUPO 2024, showcasing the Proteograph™ Product Suite's capabilities in Alzheimer’s research, population-scale plasma analysis, immune dynamics in xenotransplantation, and more. The platform enables deep, unbiased proteomic data generation at unprecedented speed and scale, driving proteomic science adoption and expansion.

Seer, Inc. presents advancements at HUPO 2024, showcasing the Proteograph™ Product Suite's power in proteomic research, including studies on Alzheimer’s Disease, population health, whole blood microsampling, and xenotransplantation. External collaborators also highlight Seer’s platform versatility.

Researchers developed a technique using neo-mannosyl human serum albumin-indocyanine green (MSA-ICG) and laparoscopic fluorescence imaging to detect and remove metastatic lymph nodes in endometrial cancer surgery, reducing complications and improving survival rates.

The 2024 chemistry Nobel was awarded to John Jumper and Demis Hassabis for developing AlphaFold, an AI tool for predicting protein structures, and David Baker for computational protein design, both significantly enhanced by AI. AlphaFold's transformative impact on protein structure prediction and design has revolutionized the field, making highly accurate structures accessible and enabling new scientific discoveries.

Korean researchers at Greenjin used second-generation genetic scissors to successfully correct plant chloroplast DNA, creating herbicide-resistant plants certified as 'non-GMO' by the USDA, with potential applications in enhanced photosynthesis and disease treatments.

A research team led by Professor Song Yong-sang developed a diagnostic method to predict chemotherapy resistance in ovarian cancer patients using a tool called the Ovarian Cancer Assay. The method, with 85% accuracy and 100% sensitivity, identifies 31 key genes linked to resistance, focusing on platinum-based chemotherapy. Clinical trials are set to begin, involving multiple institutions and supported by precision medicine companies.